Effects of alpha-2 adrenoceptor agonists during recovery from isoflurane anaesthesia in horses.
Authors: Santos M, Fuente M, Garcia-Iturralde R, Herran R, Lopez-Sanroman J, Tendillo F J
Journal: Equine veterinary journal
Summary
# Editorial Summary: Alpha-2 Agonists for Smoother Post-Anaesthetic Recovery in Horses Recovery from isoflurane anaesthesia represents a notoriously challenging period in equine practice, during which horses are vulnerable to injury and complications; Santos and colleagues investigated whether alpha-2 adrenoceptor agonists administered at emergence could improve this critical window by comparing saline controls against xylazine (0.1 mg/kg), detomidine (2 µg/kg) and romifidine (8 µg/kg) in six healthy horses following 2 hours of isoflurane maintenance. Horses receiving any of the three alpha-2 agonists demonstrated markedly superior recovery quality with substantially reduced ataxia compared to saline-treated controls, whilst romifidine produced the greatest degree of sedation; importantly, these improvements occurred without clinically significant adverse effects on cardiovascular or respiratory parameters, nor did they compromise arterial blood gas values. The findings suggest that judicious use of alpha-2 agonists at emergence—particularly xylazine or detomidine—offers practitioners a practical pharmacological strategy to facilitate calm, coordinated recoveries and mitigate the risk of trauma-related complications during this vulnerable post-anaesthetic phase. Given the inherent dangers of ataxic recoveries in large animals, this relatively simple intervention warrants serious consideration in clinical protocols, though individual patient factors and contraindications should remain central to decision-making.
Read the full abstract on PubMed
Practical Takeaways
- •Consider administering alpha-2 agonists during recovery from isoflurane anaesthesia to obtain calmer, safer recoveries with less stumbling and falling
- •Romifidine may provide superior sedation if deeper post-operative sedation is desired, though all three agonists tested were effective
- •Alpha-2 agonist use during recovery appears safe with respect to heart rate and respiratory function, supporting routine clinical application
Key Findings
- •Alpha-2 adrenoceptor agonists (xylazine, detomidine, romifidine) improved recovery quality and reduced ataxia compared to saline control during isoflurane recovery
- •Romifidine produced the greatest degree of sedation among the three agonists tested
- •Alpha-2 agonist administration during recovery prolonged recovery time without producing significant cardiorespiratory complications
- •Alpha-2 agonists may prevent complications during the critical recovery period from inhalant anaesthesia